Literature DB >> 15612602

Brain tumor treatment: chemotherapy and other new developments.

Carrie Anne Graham1, Timothy F Cloughesy.   

Abstract

OBJECTIVES: To provide a summary of chemotherapy used in the management of malignant brain tumors, including a historical perspective, current standard therapies, and promising new therapies. DATA SOURCES: Published articles, research data, and reference books.
CONCLUSION: Chemotherapy is used to treat several types of brain tumors, including primary central nervous system lymphomas, medulloblastomas, brain metastases, and malignant gliomas. New therapies, including cytostatic agents and molecular therapies, are being evaluated and used in the management of brain tumors. IMPLICATIONS FOR NURSING PRACTICE: It is essential for the oncology nurse to possess knowledge of the different types of brain tumors treated with chemotherapy, current chemotherapy regimens, new innovative therapies, and nursing management issues specific to this population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15612602

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  10 in total

1.  Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.

Authors:  Tian-Yu Fan; Hai Wang; Peng Xiang; Ya-Wei Liu; He-Zhen Li; Bing-Xi Lei; Meng Yu; Song-Tao Qi
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 2.  The Potential Role of Exosomes in the Treatment of Brain Tumors, Recent Updates and Advances.

Authors:  Zoufang Huang; Shayan Keramat; Mehrdad Izadirad; Zhe-Sheng Chen; Mohammad Soukhtanloo
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 5.738

Review 3.  Multifunctional nanoparticles for brain tumor imaging and therapy.

Authors:  Yu Cheng; Ramin A Morshed; Brenda Auffinger; Alex L Tobias; Maciej S Lesniak
Journal:  Adv Drug Deliv Rev       Date:  2013-09-20       Impact factor: 15.470

Review 4.  Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets.

Authors:  Yong Woo Lee; Hyung Joon Cho; Won Hee Lee; William E Sonntag
Journal:  Biomol Ther (Seoul)       Date:  2012-07       Impact factor: 4.634

5.  Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma.

Authors:  Nader Choucair; Zahraa Saker; Hassane Kheir Eddine; Hisham F Bahmad; Youssef Fares; Mariana Zaarour; Hayat Harati; Sanaa Nabha
Journal:  Pathologica       Date:  2022-04

Review 6.  The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials.

Authors:  Seidu A Richard; Kuugbee D Eugene
Journal:  Anal Cell Pathol (Amst)       Date:  2021-10-27       Impact factor: 2.916

Review 7.  Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches.

Authors:  Ksenia Mitusova; Oleksii O Peltek; Timofey E Karpov; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2022-09-15       Impact factor: 9.429

Review 8.  Neurological disorders and therapeutics targeted to surmount the blood-brain barrier.

Authors:  Jagat R Kanwar; Bhasker Sriramoju; Rupinder K Kanwar
Journal:  Int J Nanomedicine       Date:  2012-07-09

9.  MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.

Authors:  Hongqin Wang; Shuxian Ren; Yongming Xu; Wang Miao; Xintao Huang; Zhizhao Qu; Jinhu Li; Xiaodong Liu; Pengzhou Kong
Journal:  Anticancer Drugs       Date:  2019-01       Impact factor: 2.248

Review 10.  Carbon Dots: A Future Blood-Brain Barrier Penetrating Nanomedicine and Drug Nanocarrier.

Authors:  Wei Zhang; Ganesh Sigdel; Keenan J Mintz; Elif S Seven; Yiqun Zhou; Chunyu Wang; Roger M Leblanc
Journal:  Int J Nanomedicine       Date:  2021-07-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.